Octapharma AG - Company Profile
Powered by 
All the data and insights you need on Octapharma AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Octapharma AG Strategy Report
- Understand Octapharma AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Octapharma AG (Octapharma) is a human protein product manufacturer that focuses on developing and producing medicines through human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy, hematology, and critical care therapeutic areas. It sources plasma from company-owned plasma donation centers and other external sources. Octapharma owns plasma donation centers in the US and Germany and owns production facilities in Austria, Germany, France, Mexico, and Sweden. It’s production plants carry out plasma fractionation and purification, pharmaceutical production, research and development, product labeling, packaging, storage, and distribution. Octapharma is headquartered in Lachen, Switzerland.
Headquarters
Switzerland
Address
Seidenstrasse 2, Lachen, Schwyz, 8853
Website
www.octapharma.com
Telephone
41 55 4512121
No of Employees
11,573
Industry
Pharmaceuticals and Healthcare
Revenue (2022)
$3.0B
Octapharma AG premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Human Protein | Plasma-Based Services | - |
| Hematology | Support for Self-Sufficiency Partners | Albuminativ |
| Immunotherapy | Albunorm | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Regulatory Approval | In February, the company submitted a Biologics License Application Suppliment to the FDA, to expand the approval for wilate. |
| 2023 | Regulatory Approval | In February, the company announced the approval of Lyphilised S/D treated plasma octaplasLG for pre-hospital transfusion by European Authorities. |
| 2022 | Contracts/Agreements | In April, the company has partnered with the local authorities to provide furnished accommodation to Ukraine refugees. |
Competitor Comparison
| Key Parameters | Octapharma AG | Abeona Therapeutics Inc | Liminal BioSciences Inc | China Biologic Products Holdings Inc | Grifols USA LLC |
|---|---|---|---|---|---|
| Headquarters | Switzerland | United States of America | Canada | China | United States of America |
| City | Lachen | Cleveland | Belleville | Beijing | Los Angeles |
| State/Province | Schwyz | Ohio | Ontario | Beijing | California |
| No. of Employees | 11,573 | 84 | 43 | 2,269 | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Wolfgang Marguerre | Chairman; Chief Executive Officer | Executive Board | - | - |
| Roger Machler | Chief Financial Officer | Senior Management | - | - |
| Tobias Marguerre | Managing Director - Octapharma Nordic AB | Senior Management | - | - |
| Wolfgang Frenzel | Head - Research and Development | Senior Management | - | - |
| Josef Weinberger | Corporate Quality and Compliance Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward